endstage ischemic heart failure requiring left ventricular assist device
Conditions
Interventions
LVAS implantation and cell transplantation
Sponsors
Osaka University, Graduate School of Medicine, Division of Crdiovascular Surgery, Department of Surgery
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) patients who are in severe heart failure of NYHA class IV and do not respond to maximum medical and surgical treatment due to ischemic cardiomyopathy 2) patients who understand the purpose of this study and have family support. 3) patients who can sign the agreement to the informed concent
Exclusion criteria
Exclusion criteria: The major exclusion criteria consists of peripheral muscular dystrophy, malignancies, pregnancy, alcoholic, and positive serologic test results for human immunodeficient virus, hepatitis, human T lymphotrophic virus type 1 and syphilis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse events | — |
Secondary
| Measure | Time frame |
|---|---|
| Cardiac function, such as left ventricular ejection fraction, diastolic color kinesis index and BNP levels, and histological ezamination were evaluated. | — |
Countries
Japan
Contacts
Public ContactTomoyuki Fujita
Osaka University, Graduate School of Medicine Division of Crdiovascular Surgery, Department of Surgery
Outcome results
None listed